La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

MT Genex Salute del bilancio

Salute finanziaria criteri di controllo 5/6

MT Genex ha un patrimonio netto totale di ¥3.9B e un debito totale di ¥112.0M, che porta il suo rapporto debito/patrimonio netto a 2.9%. Le sue attività totali e le sue passività totali sono rispettivamente ¥4.8B e ¥853.0M. L'EBIT di MT Genex è ¥364.0M rendendo il suo rapporto di copertura degli interessi -36.4. Ha liquidità e investimenti a breve termine pari a ¥1.7B.

Informazioni chiave

2.9%

Rapporto debito/patrimonio netto

JP¥112.00m

Debito

Indice di copertura degli interessi	-36.4x
Contanti	JP¥1.74b
Patrimonio netto	JP¥3.90b
Totale passività	JP¥853.00m
Totale attività	JP¥4.75b

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

There's No Escaping MT Genex Corporation's (TSE:9820) Muted Earnings

Aug 06

Why Investors Shouldn't Be Surprised By MT Genex Corporation's (TSE:9820) Low P/E

Mar 08

MT Genex (TYO:9820) Has More To Do To Multiply In Value Going Forward

Apr 28

You Have To Love MT Genex Corporation's (TYO:9820) Dividend

Mar 17

Are Strong Financial Prospects The Force That Is Driving The Momentum In MT Genex Corporation's TYO:9820) Stock?

Feb 11

Will MT Genex's (TYO:9820) Growth In ROCE Persist?

Dec 31

Is MT Genex Corporation (TYO:9820) A Smart Pick For Income Investors?

Nov 18

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( ¥4.2B ) di 9820 superano le sue passività a breve termine ( ¥511.0M ).

Passività a lungo termine: Le attività a breve termine di 9820 ( ¥4.2B ) superano le sue passività a lungo termine ( ¥342.0M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: 9820 ha più liquidità del suo debito totale.

Riduzione del debito: Il rapporto debito/patrimonio netto di 9820 è aumentato da 0% a 2.9% negli ultimi 5 anni.

Copertura del debito: Il debito di 9820 è ben coperto dal flusso di cassa operativo ( 257.1% ).

Copertura degli interessi: 9820 matura più interessi di quanti ne paga, quindi la copertura dei pagamenti degli interessi non è un problema.

MT Genex Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Recent updates

MT Genex Corporation to Report Q2, 2025 Results on Nov 08, 2024

First quarter 2025 earnings released: EPS: JP¥31.59 (vs JP¥79.00 in 1Q 2024)

There's No Escaping MT Genex Corporation's (TSE:9820) Muted Earnings

New minor risk - Share price stability

Now 21% undervalued after recent price drop

MT Genex Corporation to Report Q1, 2025 Results on Aug 09, 2024

Full year 2024 earnings released: EPS: JP¥257 (vs JP¥224 in FY 2023)

MT Genex Corporation, Annual General Meeting, Jun 25, 2024

Upcoming dividend of JP¥40.00 per share

Why Investors Shouldn't Be Surprised By MT Genex Corporation's (TSE:9820) Low P/E

Investor sentiment improves as stock rises 15%

MT Genex Corporation to Report Fiscal Year 2024 Results on May 13, 2024

Third quarter 2024 earnings released: EPS: JP¥86.32 (vs JP¥69.70 in 3Q 2023)

MT Genex Corporation (TSE:9820) agreed to acquire Itec Ltd. from Yasushi Ide.

MT Genex Corporation to Report Q3, 2024 Results on Feb 09, 2024

Second quarter 2024 earnings released: EPS: JP¥69.64 (vs JP¥27.88 in 2Q 2023)

MT Genex Corporation to Report Q2, 2024 Results on Nov 10, 2023

First quarter 2024 earnings released: EPS: JP¥78.96 (vs JP¥59.48 in 1Q 2023)

MT Genex Corporation to Report Q1, 2024 Results on Aug 07, 2023

Full year 2023 earnings released: EPS: JP¥224 (vs JP¥197 in FY 2022)

MT Genex Corporation, Annual General Meeting, Jun 27, 2023

Upcoming dividend of JP¥40.00 per share at 1.7% yield

Third quarter 2023 earnings released: EPS: JP¥69.61 (vs JP¥51.12 in 3Q 2022)

MT Genex Corporation to Report Q3, 2023 Results on Feb 10, 2023

No independent directors

Second quarter 2023 earnings released: EPS: JP¥27.86 (vs JP¥75.28 in 2Q 2022)

MT Genex Corporation to Report Q2, 2023 Results on Nov 11, 2022

Investor sentiment improved over the past week

First quarter 2023 earnings released: EPS: JP¥59.45 (vs JP¥35.32 in 1Q 2022)

Investor sentiment improved over the past week

MT Genex Corporation to Report Q1, 2023 Results on Aug 05, 2022

Full year 2022 earnings released: EPS: JP¥197 (vs JP¥211 in FY 2021)

MT Genex Corporation, Annual General Meeting, Jun 23, 2022

No independent directors

MT Genex Corporation to Report Fiscal Year 2022 Results on May 13, 2022

Upcoming dividend of JP¥40.00 per share

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: EPS JP¥75.21 (vs JP¥36.25 in 2Q 2021)

First quarter 2022 earnings released: EPS JP¥35.30 (vs JP¥39.03 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥211 (vs JP¥322 in FY 2020)

MT Genex (TYO:9820) Has More To Do To Multiply In Value Going Forward

Upcoming dividend of JP¥40.00 per share

You Have To Love MT Genex Corporation's (TYO:9820) Dividend

MT Genex Corporation to Report Fiscal Year 2021 Results on May 12, 2021

Third quarter 2021 earnings released: EPS JP¥60.31 (vs JP¥28.81 in 3Q 2020)

Are Strong Financial Prospects The Force That Is Driving The Momentum In MT Genex Corporation's TYO:9820) Stock?

MT Genex Corporation to Report Q3, 2021 Results on Feb 12, 2021

Will MT Genex's (TYO:9820) Growth In ROCE Persist?

Is MT Genex Corporation (TYO:9820) A Smart Pick For Income Investors?

Second quarter 2021 earnings released: EPS JP¥36.25

Market pulls back on stock over the past week

MT Genex Corporation to Report Q2, 2021 Results on Nov 09, 2020

MT Genex Corporation (JASDAQ:9820) agreed to acquire Chiyoda Me Service Corporation from Takashi Sawai and other shareholders.

New 90-day low - JP¥2,600

First quarter earnings released

MT Genex Corporation to Report Q1, 2021 Results on Aug 07, 2020

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane